2.1 Sample description.
Demographic, clinical and laboratory characteristics of the study subjects are provided in Tables 2-4. EA and non-EA patients were comparable regarding most demographic and clinical features except for BMI, which was higher in the latter.
While the studied groups did not differ significantly in regard to lung function parameters, EA patients had more prominent absolute indices of airflow limitation (lower forced expiratory volume in 1 second; FEV1) and more favorable obstruction reversibility (higher DFEV1), while non-EA patients had lower total lung capacity (TLC), possibly due to overrepresentation of obese subjects in this group. HRCT indices of airway remodeling were significantly more prominent in the EA group, consistent with the differences in lung function, suggesting computed tomography as superior to spirometry in detecting advancement of airway remodeling.
2.2 Identification and study of differentially expressed genes.
After background correction, quantile normalization and filtration for coefficients of gene expression variation between 0.3 and 10, 14823 annotated gene products were included in subsequent analyses. Expression levels of 20 genes differed significantly between EA and non-EA by unadjusted p-value. According to automated literature mining, at least one of them was described in the context of asthma alone in one paper, three in the context of inflammation-related keywords over 8 papers and 9 in the context of remodeling-related keywords over 80 papers (Tab. 5, Fig. 1).
After adjustment for false discovery rate, no gene’s expression level was found to significantly differ between EA and non-EA, concluding DEG analysis and indicating unconfounded pure differential co-expression discovery11.
2.3 Identification and study of differentially co-expressed genes.
Hierarchical cluster analysis revealed a total of 23 groups of DCGs. A single group consisting of 32 genes with the highest mean, pairwise difference between the correlation matrices of gene expressions in the two asthma groups was chosen for subsequent analyses (Tab. 6).
Only 5 of the 32 genes co-occurred with asthma over 9 papers, 6 with allergy/inflammation-related keywords over 98 papers and 15 with remodeling-related keywords over 133 papers (Fig. 2). Abundance of significant correlations between DCGs’ expression levels within EA group may indicate its pathogenetic consistency, contrary to less correlated DCGs in the non-EA group (Fig. 3). The resulting list of candidate genes as well as their interactors and regulatory networks (Fig. 4-6) which may differentiate airway inflammation and remodeling mechanisms specific to EA and non-EA are discussed.
2.4 Gene set enrichment analysis (GSEA) of DCGs.
None of the DCGs were significantly enriched for ontology terms at adjusted p-value (false discovery rate) < 0.05, expectedly, given the small gene set size. The results were ranked based on combined p-value and z-score.
2.4.1 Cell type-specific histone modifications related to expression of DCGs.
Fifteen of the 32 DCGs (all up-regulated in the EA) matched differential expression pattern related to histone modifications H3K9ac and H3K27me3 of human lung fibroblast hg19, suggesting them as the likely source of the gene expression signal (Tab. 7). H3K9ac and H3K27me3 are the two histone modifications of dominant and opposite role in regulation of neuroectodermal differentiation (H3K9ac) or pluripotency (H3K27me3)15. With H3K27me3 previously linked to epithelial-mesenchymal transition (EMT) and extracellular matrix degradation upon treatment of cell culture with TNF-a and TGF-b16, up-regulation of the genes related to both histone modifications in our study could indicate their role in ongoing EMT in EA, consistent with the abundance of eosinophil-derived TGF-b1 in this disease phenotype17.
2.4.2 Gene ontology associations.
Molecular functions and biological processes associated with DCGs by gene ontology are listed in Tab. 8-9. They include phenomena significant in the pathogenesis of asthma and airway remodeling, such as T-cell receptor binding, MHC II protein complex binding, immunoglobulin secretion, myeloid cell apoptosis, regulation of cellular response to growth factors (e.g. TGF-b) and metalloendopeptidase inhibitory activity, as further discussed in section 3.5.
2.4.3 Kinase perturbation studies.
Kinase perturbation studies included in Gene Expression Omnibus (GEO) database indicate differential expression of several DCGs upon knockout of the following kinases (Tab. 10):
(1)TGF-b receptor II (TGFBR2): down-regulation of CCT7, EPS15, MRPL14;
(2)Homeodomain-interacting protein kinase 1 (HIPK1): down-regulation of GPI, MAEA, STRN4;
(3) Inhibitor of nuclear factor kappa-B kinase subunit epsilon (IKBKE): up-regulation of DGLUCY, RAPH1, ASB3.
These kinase-dependent DCGs might indicated differential activity of the related pathways and have pathogenetic role in EA. The ligand of TGFBR2, TGF-b, has well-established role in asthma and airway remodeling, as further discussed in section 3.5, while the receptor itself was found to be involved in T-cell differentiation. The role of HIPK1 was to date only described in fetal angiogenesis activated by TGF-β-TAK1 pathway18, apoptosis induced by TNF-a and prevention of MAP3K5-JNK activation. Our study links HIPK1 with eosinophilic asthma through the pattern of DCGs, a suggestion reinforced by association between MAP3K5 and atopy19. IKBKE is a known target of the nuclear factor κB (NFκB), a transcription factor involved in chronic inflammation of established role in asthma pathogenesis, including remodeling.
2.5 Literature-based assessment of individual DCGs for mechanistic role in EA and bronchial remodeling.
Individual DCGs are discussed below in the following order: gene’s function, possible involvement in the disease and interaction with other DCGs from our study (shown in bold).
2.5.1 Sodium/potassium-transporting ATPase subunit beta-1 (ATP1B1)
The sodium-potassium pump is a heterodimer composed of the catalytic subunit alpha and non-catalytic subunit beta. The latter may be expressed in several cell types and conditions involved in asthma pathogenesis:
(1) In the epithelia, the beta-1 subunit may be related to epithelial sheathing as it contributes to formation and stabilization of intercellular junctions. It regulates the number of pumps transported to plasma membrane through assembly of alpha/beta heterodimers, which can act as positive or negative regulator of intracellular adhesion, depending on its proportion to FXYD5, a membrane protein involved in chemokine up-regulation and loosening of cell adhesion through down-regulation of E-cadherin20.
(2) In cytomegalovirus (CMV) infection, previously linked to asthma pathogenesis via promotion of Th2 response2122, subunit beta 1 was found to co-localize with viral UL136 protein suggesting involvement in cell-to-cell spread of the infection23. It is also upregulated in human neutrophils during respiratory syncytial virus (RSV) infection, a trigger of asthma exacerbations.
(3) In lymphocytes, subunit beta 1 is known to be up-regulated in response to phytohemagglutinin, suggesting possible role as marker of their activation status24 and AT1B1 was among four genes upregulated in human lymphocytes under Th17-polarizing conditions.
(4) Decreased activity the pump elevates intracellular free calcium concentration,
a phenomenon linked to the activation of inflammatory cells and airway smooth muscles (ASM) resulting in increased proliferation, spreading, and eosinophil-attracting eotaxin-1 release in experimental conditions25262728.
(5) In the goblet cells, IL-4 produced by Th2-lymphocytes causes up-regulation and translocation of ATP1B1 from basal to apical aspect of the cell, where it colocalizes with H+/K+-ATPase, ATP12A, being required for its function implied in mucous secretion in asthma and cystic fibrosis29.
(6) ATP1B1 is modulated by PXK, which is thought to participate in regulation of electrical excitability and synaptic transmission by, in part, epidermal growth factor (EGF) receptor ligand-induced internalization30, both processes being postulated to play a role in airway hyperreactivity in asthma.
ATP1B1, CLC, FADS6, FBN3, RECK and SLC19A1 share a common transcription factor Sp1313233 involved in multiple cellular processes ranging from cell proliferation and differentiation to immune response, their specific function being highly dependent on post-translational modification. Sp1 expression and DNA binding activity are increased in CMV infection34, a positive-feedback loop given ATP1B1’s role in cell-to-cell virus transmission. Furthermore, Sp1 has an established role in asthma pathogenesis as a transcription factor for (1) lipooxygenase ALOX535, which promoter region’s polymorphism affects asthma control, and (2) vascular endothelial growth factor (VEGF), hypersecreted from ASM in asthma and contributing to remodeling. Of note, both ATP1B1 and RECK are implied to take part in airway remodeling in mustard lung36, adding to evidence of Sp1-regulated genes in airway pathology.
ATP1B1 was one of the genes included in transcriptomic cluster TAC3 of patients with moderate to high sputum eosinophilia in the U-BIOPRED cohort of Th2-dependent asthma37, with our study being the second to indicate the link.
Of note, as ATP1B1 is involved in kidney proximal tubule bicarbonate reclamation, aldosterone-regulated sodium reabsorption and kidney stone formation, common regulation of ATP1B1 in both bronchi and renal tubule may underlie apparent higher incidence of nephrolithiasis and chronic kidney disease in asthma patients3839.
2.5.2 Charcot-Leyden crystal protein (CLC)
Charcot-Leyden crystal protein or galectin-10 (Gal-10) is an atypical galectin preferentially binding b-mannosides. It takes part in sequestration and vesicular transport of eosinophil granule cationic ribonucleases: eosinophil-derived neurotoxin and eosinophil cationic protein40 and was found to poses lysolecithin acylhydrolase (lysophospholipase; phospholipase B) activity. Released upon degranulation, it is ubiquitous in sputum of EA patients and considered a marker of eosinophilic inflammation. It is thought to regulate immune responses through the recognition of cell-surface glycans and may possess IgE-binding capability. Furthermore, through lysophospholipase activity, it may hydrolyze 1) phospholipids, producing arachidonic acid for synthesis of eicosanoids of important role in asthma pathogenesis and 2) surfactant phosphatidylcholine, leading to surfactant dysfunction and small airway closure41.
Recently, the existence of regulatory CD16-high eosinophils with distinct suppressor function on T-cell proliferation has been suggested, with their function likely mediated by Gal-10 in immune synapses between eosinophils and lymphocytes42. Furthermore, Gal-10 was recently found to be expressed in human CD4(+)CD25(+)Foxp3(+) T regulatory cells (Treg), while nearly absent in resting and other activated CD4(+) T cells. In Treg cells this lectin is essential to limit proliferation and suppressive function, similarly to the above CD16-high eosinophils43.
CLC shares transcription factor Sp1 with ATP1B1, RECK, FBN3, FADS6 and SLC19A1, which points to a possible involvement in a common biological process.
Consequently, CLC was included in transcriptomic cluster TAC1 of patients with high sputum eosinophilia in the abovementioned U-BIOPRED asthma study37 and associated with asthma in an epigenome-wide association study (EWAS)44.
Since galectins can frequently act as both positive and negative modulators of the same processes, possibly depending on isoform plasticity, posttranslational modifications, localization or cofactors45, further research is needed to assess if galectin-10 can be influenced to act as an anti-inflammatory factor, similar to galactin-9 (Gal-9). This galectin, released by various cell types plays a substantial role in control of effector cells and Th1/Th2 balance. It is known to be upregulated upon CMV infection through induction of IFN-b46 and released upon calcium-mediated exocytosis47. It is able to reduce Th2-associated airway inflammation and airway hyperresponsiveness through binding with T cell immunoglobulin mucin domain 3 (Tim-3), persistently expressed on functional T-cells during chronic viral infections. By inducing maturation of monocyte-derived dendritic cells it promotes Th1-associated immune response. It also triggers apoptosis of mature Th1 cells by aforementioned Tim-3 receptor, preventing degranulation of mast cells by forming complex with IgE48 and inhibits interaction-dependent migration of inflammatory cells via CD44 pathway 49–52. These properties elicit galectin-9 and possibly galectin-10 as potential candidates for development of novel protein drugs for the treatment of asthma.
2.5.3 Pregnancy-specific beta-1-glycoprotein 2 (PSG2)
PSG2 stimulates transcription of FOXP3 in mononuclear cells and CD4+ T cells, thus providing signal for Treg and Th17 differentiation, a process consistent with CLC/Gal-10 expression on CD4(+)CD25(+)Foxp3(+) Treg cells, with loss of FOXP3 expression causing Th2-differentiation53. Human PSG proteins are able to activate latent TGF-b bound to the extracellular matrix and cell membrane, thus enabling its pleiotropic action54 involved in suppression of innate immunity, Th17 differentiation, expression of T-cell regulatory phenotype but also up-regulation of periostin, a component of subepithelial fibrosis in asthma55.
Co-expression of the two genes involved in limitation of Th2- and induction of Th17-differentiation, CLC and PSG2, in EA patients suggests both a counterweight mechanism to limit Th2-response and a possible role behind heterogeneity of Th2-high asthma, recently proposed to be divided into IL-5-high/IL-17F-high asthma (with mixed granulocytic infiltration) and IL-4/IL-13-high asthma (with eosinophilic infiltration alone)56.
2.5.4 EPS8 like 1 (EPS8L1)
EPS8L1 encodes a protein related to the epidermal growth factor receptor kinase substrate 8 or Eps8 involved in actin remodeling. EPS8L1 itself is known to play a role in T-cell receptor binding, membrane ruffling and remodeling of actin cytoskeleton through F-actin organization by stimulating guanine exchange of SOS1, thus taking part in regulation of cell locomotion. In a murine knockout models, EPS8L1 was required for EGF-dependent membrane ruffling 57 and Eps8 was required for maintaining front-to-back polarity of dendritic cell, both features required for cell migration58. Furthermore, Eps8 takes part in Cdc42–IRSp53–Eps8 pathway involved in formation of filopodia and cell migration, with EPS8L1 being the only Eps8-related protein associating with IRSp53 and thus possibly involved in the process59.
No direct link between EPS8L1 an asthma was made to date.
Cell migration is a regulated by Rho GTPases, of which RhoBTB2 is an example, although no associations between Eps8 or EPS8L1 exist to date.
2.5.5 Rho related BTB domain containing 2 (RHOBTB2)
RHOBTB2 is an atypical member of the Rho family of small GTPases which control cell migration, invasion and cycle and is required for expression of CXC motif ligand 14 (CXCL14). CXCL14 is a chemoattractant that controls dendritic cell activation, leukocyte migration and angiogenesis and an autocrine growth factor for fibroblasts facilitating their migration60 and which expression is lost through unknown mechanisms in a wide range of epithelial cancers61; e.g., loss of RhoBTB2 expression correlates with downregulation and loss of CXCL14 secretion by head and neck squamous cell carcinoma cell lines, whereas reintroduction of RhoBTB2 restores CXCL14 secretion62.
In a genome-wide association study conducted in Australia, CXCL14 was one of the six most-associated loci with the asthma susceptibility 63. Moreover, effects of exposure to tobacco smoke pollution are thought to be mediated through the CXCL14. The experimental data suggests differential effects of occasional64 and chronic65 tobacco exposure on CXCL14 expression, as well as differential effects of tobacco smoking on airway eosinophilia (elevated in chronic smokers, but attenuated by occasional exposure in non-smokers).
While CXCL14 receptor is not yet identified, migration of antigen-presenting cells (APCs) towards CXCL13, the ligand of CXCR5, is significantly potentiated in the presence of CXCL14, possibly contributing to mucosal recruitment of inflammatory cells66, including APCs and Th17 lymphocytes expressing CXCR5 as well. Regulation by RhoBTB2 suggests its role in disease mediated through CXCL14 and resulting migration of leukocytes, dendritic cells and possibly epithelial-mesenchymal transition of fibroblasts.
Furthermore, RhoBTB2 is a substrate adaptor for Cul3-based ubiquitin ligase complex known to play a role in a Keap1-guided degradation of antioxidative Nrf transcription factor implicated in asthma pathogenesis67. As Keap1 is believed to compete with other BTB proteins for culling-3 binding, down-regulation of RhoBTB2 may leave E3 ubiquitin ligase open for adaptor Keap1-BTB-mediated ubiquitination and degradation of antioxidative Nrf2, thus suppressing its transcriptional activity and promoting oxidative stress. Recent studies indicate that RhoBTB2 is involved in the Hippo signaling pathway through LKB1 regulation, with loss of RhoBTB2 leading to ubiquitination and loss of LKB1 as well as increased YAP activity of role in asthma pathogenesis. Available GEO dataset indicates correlation between RhoBTB2 expression and asthma exacerbation, with significant difference in expression between pools of peripheral blood mononuclear cells from exacerbated and convalescent asthma patients (GDS361568). Furthermore, RhoBTB2 was one of the genes which expression changed significantly after bronchial thermoplasty69.
RhoBTB2’s GTPase activity as well as interaction with Cul3 requires Hsp90, a chaperone regulated by CCT770. Its role in membrane ruffling makes a possible link with aforementioned EPS8L1.
2.5.6 Ras association (RalGDS/AF-6) and pleckstrin homology domains (RAPH1)
RAPH1 is a member of Mig10/Rap1-interacting family of adaptor proteins regulating actin dynamics. As a mediator of localized membrane signaling implicated in the regulation of lamellipodial dynamics it regulates cell migration, and its internalization negatively regulates cell adhesion, possibly contributing to epithelial sheathing. Phosphorylation of RAPH1 by C-abl oncogene takes part in its coordination of actin remodeling in response to external stimuli61. As a target gene of regulatory miR-203, it facilitates keratinocyte migration and wound healing71. While no direct role of RAPH1 in airways was reported, miR-203 is known to inhibit proliferation in ASM cells through attenuation of c-Abl expression and phosphorylation by ERK1/2, a pathway involved in epithelial-mesenchymal transition in airways, of which RAPH1 is a phosphorylation target. Furthermore, both ERK1/2 and RAPH1 are affected by histone demethylase KDM2A, implicated in lung carcinogenesis72. Because of its place at the intersection of KDM2A, miR-203, c-Abl and ERK1/2, RAPH1 upregulation in EA patients suggests its role in ASM proliferation, as well as epithelial sheathing and epithelial-mesenchymal transition.
2.5.7 Signal recognition particle receptor beta subunit (SRPRB)
SRPRB is one of two subunits of the signal recognition particle receptor (SRP) required for co-translational targeting of secretory and membrane proteins. With the alpha subunit targeting SRP-ribosome-nascent polypeptide complexes to translocon, the beta subunit is a transmembrane GTPase which anchors the alpha subunit to the endoplasmic reticulum (ER).
Protein-protein interaction studies suggest SRPRB as involved in trafficking of proteins relevant for asthma pathogenesis: (1) beta-2-adrenergic receptor, (2) caspase-4 (a protein of increased expression in alveolar macrophages implied in inflammatory cell death contributing to tissue injury in asthma (https://www.nature.com/articles/s41467-020-14945-2), (3) TNFRSF14 (a receptor for TNF superfamily member TNFSF14 found to promote Th2 lymphocytes and airway remodeling) https://www.nature.com/articles/ncomms13696 and (4) glutathione S-transferase kappa 1 (implied in susceptibility to childhood asthma)73.
ILK1, an integrin-linked kinase responding to signals from the extracellular matrix, including injury, and regulating basal stem cell activity and ASM differentiation74 links SRPRB to CCT7 through affinity capture protein-protein interaction of unknown biological significance.
2.5.8 Ankyrin repeat domain 26 pseudogene 1 (ANKRD26P1)
ANKRD26P1 is a pseudogene of little known function. It interacts with MAGEA-675, a protein encoding epitopes presented with HLA-DRB1*0401. Presentation of these epitopes recognized by CD4(+) T-cells from patients with melanoma or renal cell carcinoma enhances T-cell response against cells expressing both proteins in HLA-DRB1*0401 patients76. The same haplotype was previously associated with severity of asthma, incidence of rheumatoid arthritis and eosinophilic granulomatosis with polyangiitis, an autoimmune disease resulting in eosinophilic tissue infiltrates and EA phenotype in its clinical presentation77,78.
MAGEA-6 is up-regulated upon exposure of cell culture to macrophage migration inhibitory factor (MIF), a pro-inflammatory factor known to play a role in asthma and chronic obstructive pulmonary disease79.
These findings suggest that genetic factors such as human leukocyte antigens may be associated with susceptibility to EA and that it may be mediated through T-cell response against cells expressing ANKRD26P1 and MAGEA-6, possibly in response to MIF and resulting in T-cell production of IL-4 and IL-13 that drive eosinophilic inflammation.
2.5.9 Chaperonin containing TCP1 subunit 7 (CCT7)
CCT7 is a molecular chaperon, member of chaperonin containing TCP1 complex (CCT; TRiC) assisting folding of proteins like actin and tubulin and regulating Hsp90 chaperone.
Its expression increases in fibrotic wound healing and is essential for the accumulation of α-smooth muscle actin (α-SMA) in fibroblasts and cell differentiation to myofibroblasts80. CCT7 was recently found to coimmunoprecipitate with thromboxane A2 receptor as well as β2-adrenergic receptor from human HEK 293 cells and its depletion resulted in reduced cell surface expression of both receptors81; a fact significant given the momentous role of both G-protein coupled receptors in asthma pathogenesis. Two-hybrid screening revealed interaction between CCT7 and ANXA1, which deficiency causes spontaneous airway inflammation and hyperresponsiveness in murine studies82.
Notable is the CCT7’s central position in the PPI network of multiple DCGs and their interactors of high asthma literature coverage (Fig. 4) and involvement in epithelial-mesenchymal transition, implying regulatory function of the CCT/TRiC complex in asthma pathogenesis, involving e.g. Hsp90-dependent GTPase activity of RhoBTB2.
2.5.10 Deiodinase iodothyronine type III (DIO3)
DIO3 product catalyzes the inactivation of thyroid hormone by inner ring deiodination of the prohormone thyroxine (T4) and the bioactive hormone 3,3',5-triiodothyronine (T3) to inactive metabolites, 3,3',5'-triiodothyronine (RT3) and 3,3'-diiodothyronine (T2), respectively. DIO3 is thought to prevent fetal tissues from exposure to adult-level concentrations of thyroid hormones.
TGF-b is known to induce DIO3 expression in various cell types, including lung fibroblasts. Of note, deiodinase type III is a selenoprotein while selenium deficiency has been suggested to take part in inflammatory diseases including asthma83 through contribution to oxidative stress, a mechanism thought to underlie asthma exacerbations in hyperthyroidism. As oxidative stress is implied to induce DIO3 expression, asthma exacerbations in selenium deficiency are aggravated through impaired DIO3 function and increased tissue exposure to active thyroid hormones. No direct link between DIO3 and asthma has been made to date, however, its upregulation might be a response to oxidative stress, activation of fetal genes due to tissue repair (along with FBN3 and GPI, below) or adult overexpression of genes hypermethylated prenatally, contributing to the hypothesis of prenatal epigenetic changes as predisposing to asthma development52. Promotor of the above-mentioned ATP1B1 has sequences binding thyroid hormones (TRE), forming a link to upregulation of both ATP1B1 and DIO3 in our study.
2.5.11 Epidermal growth factor receptor pathway substrate 15 (EPS15)
EPS15 is a protein involved in the clathrin-dependent internalization of ligand-inducible tyrosine kinase receptor (RTK) types (including EGFR, TGF-b receptors and integrin b-1) as well as cell adhesion molecules (integrins, E-cadherin), receptors relevant for bronchoconstriction (β2-adrenergic and M3-muscarinic receptors) and antigen-presenting major histocompatibility class II proteins.
EPS15 is also necessary for non-clathrin-dependent endocytosis of EGFR and TGF-b, with knockout models resulting in attenuated TGF-β-induced Smad2 phosphorylation84 of role in fibroblast to myofibroblast transition85.
EPS15 forms PARK2-EPS15-EGFR complex with parkin, an E3 ubiquitin ligase influenced by IL-13 and known to enhance airway mitochondrial DNA release contributing to inflammation86. Since IL13-stimulated parkin aids mono-ubiquitination of EPS15 thus preventing RTKs internalization and potentializing the effects of TGF-b, it forms a link between the two pro-fibrotic cytokines as well as mtDNA-mediated inflammation.
EPS15L1, a protein of suggested role in the process of receptor endocytosis, coimmunoprecipitates with EPS15 and is one of the genes associated with asthma in an EWAS study44 and EPS15 transcript is upregulated in human ASM cells upon their stimulation87.
EPS15 and TTC3 (a gene homologous with TTC3P1) are potential binding partners of Eps15 homology domain-containing 1 (EDH1), a protein involved in endocytic receptor recycling88.
2.5.12 Fatty acid desaturase 6 (FADS6)
FADS6 is an peroxisomal enzyme of oxidoreductase activity taking part in aerobic very long chain-polyunsaturated fatty acids (PUFAs) biosynthesis. By desaturating linoleic acid to g-linoleic acid, it contributes to synthesis of arachidonic acid, precursor of eicosanoids of established role in asthma pathogenesis, in a similar fashion to FADS1 and FADS2 implicated in asthma pathogenesis8990919293. FADS6 is regulated by hsa-miR-331-3p, a micro-RNA post-transcriptional regulator associated with lung function in asthma, with our study supplying evidence for the mechanism of such association being mediated through FADS694. FADS6 promoter binds factors reported to influence asthma risk: EZH2, as well as abovementioned Sp1, a transcription factor for ATP1B1, FBN3, RECK and SCL19A1.
2.5.13 Fibrillin 3 (FBN3)
Fibrillins are components of extracellular calcium-binding microfibrils, which occur either in association with elastin or in elastin-free bundles and act as structural support important for extracellular matrix integrity. Like PSG2, fibrillins may be involved in regulation of TGF-b activity through association with latent TGF-b binding proteins. Physiological FBN3 expression was described only in fetal developing bronchi9596, but its mutations have been found in lung cancer97. It shares a common transcription factor Sp1 with ATP1B1, FADS6, RECK, SLC19A133. Up-regulation of the FBN3 gene in the current gene set might both reinforce the hypothesis of fetal program execution during bronchial remodeling (together with GPI and DIO3), regulation of signaling through latent TGF-b and add to a weak association between lung cancer and asthma98.
2.5.14 Glucose-6-phosphate isomerase (GPI)
GPI expresses differential function depending on location, being (1) an intracellular glycolytic enzyme that interconverts glucose-6-phosphate and fructose-6-phosphate (thus taking part in glycolysis, gluconeogenesis and pentose phosphate pathway), (2) an extracellular neurotrophic factor neuroleukin that promotes survival of skeletal motor neurons and sensory neurons in fetal development, (3) a lymphokine that induces immunoglobulin secretion and (4) an autocrine motility factor (AMF) acting as an angiogenic factor.
GPI has a proven pathogenetic role in rheumatoid arthritis, acting as an autocrine synovial fibroblast proinflammatory cytokine resulting in proliferation, apoptosis inhibition and secretion of tumor-necrosis factor (TNF)-a and IL-1β99. Immunization of murine CD4(+) T-cells against GPI causes experimental model polyarthritis with production of proinflammatory TNF-a, IL-17 and IL-6 and anti-GPI autoantibodies are detectable in some human rheumatoid arthritis patients. GPI was found to be a direct regulator VEGF-mediated angiogenesis in rheumatoid arthritis, with both proteins being up-regulated by HIF-1a, a transcription factor involved in airway remodeling. Though rheumatoid arthritis is classically considered as Th1-dependent disease, it seems to share genetic risk factors and elements of pathogenesis with asthma100. Further studies are needed to assess if anti-GPI is present in sputum of asthma patients similarly to anti-eosinophil peroxidase and anti-IgE autoantibodies and if VEGF-mediated airway remodeling is regulated by GPI in similar fashion to that seen in rheumatoid arthritis.
As an enzyme taking part in glycolysis, it may affect glucose metabolism in the airway epithelia, where hyperglycemia and impaired glucose transport induce cell proliferation101. Association with asthma in an EWAS44 adds evidence of its pathogenetic role. Its role in fetal development along with DIO3 and FBN3 may be indicative of fetal genetic program execution in asthmatic airways.
2.5.15 Mitochondrial ribosomal protein L14 (MRPL14)
MRPL14 is a nuclear gene that encodes part of two intersubunit bridges in the assembled mitochondrial ribosome required for mitochondrial translation. Related to asthma in a genome-wide association study102 and controlled by MYC transcription factor similarly to DGLUCY, it may be involved in asthma-specific mitochondrial biogenesis and accumulation in ASM.
2.5.16 Olfactory receptor family 52 subfamily I member 1 (OR52I1)
OR52I1 is an olfactory receptor functioning by CaBP/Cam-dependent inhibition of calcium channel, a function which may be influenced by CABP5 due to functional replaceability with calmodulin. While no link between OR52I1 and asthma was found to date, other olfactory receptors like OR1D2 and OR2AG1 are known to be expressed in ASM cells and their activation by amyl butyrate was shown to inhibit histamine-induced ASM contraction. OR52I1 and CABP5 may thus be involved in pathology of airway hyperreactivity in asthma of undetermined significance.
2.5.17 Protein phosphatase 2 regulatory subunit B beta(PPP2R3B)
PPP2R3B might modulate its substrate selectivity and catalytic activity and direct the localization of the catalytic enzyme to a particular subcellular compartment. Also known as PR48, it regulates cell cycle progression likely by controlling initiation of DNA replication103. It’s downregulation in EA may indicate increased airway or inflammatory cell proliferation.
2.5.18 Reversion inducing cysteine rich protein with kazal motifs (RECK)
RECK is a membrane-anchored negative regulator of matrix metalloproteinase-9 (MMP)-9 able to suppress its secretion and enzymatic activity. MMP-9, a gelatinase, is known to be secreted by epithelial cells, neutrophils and eosinophils in response to allergen challenge or TNF-a and was previously linked to both eosinophilic infiltration into the bronchial wall and remodeling as a major MMP involved in asthma104. Its activity is increased in sputum of asthmatic patients and correlates with loss of FEV1 in response to allergens105. Furthermore, RECK down-regulation by oncogenic signals may facilitate tumor invasion and metastasis through regulation of MMP-2 and MT1-MMP, further linking asthma and carcinogenesis. It shares a common transcription factor Sp1 with ATP1B1, FADS6, FBN3 and SLC19A132.
2.5.19 Scavenger receptor cysteine rich family member with 4 domains (SSCRB4D)
SSCRB4D belongs to the scavenger receptor cysteine-rich (SRCR) superfamily of highly conserved proteins involved in the development of the immune system and regulation of immune responses. SSCRB4D may be associated with asthma by being one of the target genes of BACH1, involved in the response to oxidative stress and previously associated with asthma in an EWAS study44.
2.5.20 Stomatin like 3 (STOML3)
STOML3 modulates mechanotransduction channels and acid-sensing ion channels (ASIC) proteins and potentiates PIEZO1 and PIEZO2 function by increasing their sensitivity to mechanical stimulations. Studies in animal models suggest that mechanotransduction may play a role in hyperresponsiveness of the airways in asthma, while PIEZO1 deficiency decreases cell adhesion and increases migration of lung epithelial cells106, a feature of asthmatic bronchial remodeling107.
2.5.21 Striatin-4 (STRN4)
STRN4 belongs to a family of proteins binding calmodulin in a calcium-dependent matter, which may function as scaffolding or signaling protein. It is known to co-localize with protein phosphatase 2A (PP2A) acting as a regulatory subunit of the STRIPAK kinase-phosphatase complex involved in multiple cellular processes. Animal studies suggest that STRIPAK might be involved in cell cycle control, cell adhesion, migration, epithelial integrity and epithelial-to-mesenchymal transition.
STRN4, by inhibition of MAP4K4 kinase, is considered the key regulator inhibiting the Hippo pathway involved in asthma pathogenesis108. In T-cells, deficiency of MAP4K4 results in Th17 differentiation with IL-6 and IL-17 expression109. In a study of asthmatic patients, miRNAs expressed in the airways frequently targeted MAP kinases including MAP4K4110, suggesting their involvement in the disease.
STRN4 itself was also proposed as a part of mechanism to control dendritic spine morphology, adding to possible neuronal involvement in airway disease.
STRN4 is one of the genes associated with asthma in an EWAS44.
Through STRN4, STRIPAK interacts with Mob3, NDPK, dynamin and abovementioned EPS15 to take part in regulation of clathrin-dependent endocytosis (e.g. of EGF, TGF-b or b2-adrenergic receptors)111.
2.5.22 Tetratricopeptide repeat domain 3 pseudogene 1 (TTC3P1)
TTC3P1 is a pseudogene resembling TTC3, a E3 ubiquitin-protein ligase that mediates ubiquitination of phosphorylated Akt (AKT1, AKT2 and AKT3) as part of negative feedback required to control Akt levels after pathway activation. TTC3 contributes to TGF-b1-induced epithelial-mesenchymal transition any myofibroblast differentiation, forming a direct link with bronchial remodeling112. TTC3 may also play a role in neuronal differentiation inhibition via its interaction with CIT, associated with asthma in GWASdb database102, a fact of potential significance for the neuronal involvement in the disease113. As an apparently transcribed pseudogene, TTC3P1 may regulate TTC3 function. Membership in a E3 ligase complex associated with CUL3 links TTC3 to RhoBTB2 while involvement in Akt pathway makes an association with ASB3.
2.5.23 Calcium binding protein 5 (CABP5)
CABP5 product inhibits calcium-dependent inactivation of L-type calcium channel, thus increasing cell excitability. While primarily involved in the transmission of light sensation in the retina, it was reported in T-cells including Th1, Th17, mucosa-associated invariant T (MAIT) cells and B-cells, being differentially expressed in allergic asthma patients114). Together with the involvement in stimulating neurite outgrowth and vesicle exo- as well as endocytosis in PC12 cells, these facts suggest that CABP5 plays a role in immune reactions, neuronal growth (a feature of airway remodeling) and vesicle handling. Able to functionally replace calmodulin, it may potentially interact with striatin in clathrin-dependent membrane receptor endocytosis, thus relating CABP5 to STRN4 and EPS15115.
2.5.24 Ribosomal protein S13 (RPS13)
RPS13 is a component of the 40S ribosomal subunit essential for eukaryotic protein synthesis and regulated through redundant mechanisms, hence described as a reference housekeeping gene. However, it is known to take part in G1 to S cell phase transition and was featured in cluster 1 of asthma-linked modules obtained from the combination of differential gene expression and GWAS study of the U-BIOPRED project116. Furthermore, it forms TNF-a/NF-Kappa B signaling complex of established role in asthma67. These data provide arguments for viewing RPS13 as an active player in asthma pathogenesis and reevaluate it as a reference housekeeping gene of seemingly stable expression across biological conditions. Affinity capture studies indicate interactions of RPS13, CCT7 and EPS15 with VCAM1, ITGA4, FN1 proteins involved in cell-cell and cell-extracellular matrix adhesion, with VCAM and FN1 both binding to ITGA4, as subunit of integrin a4b1. While the nature of the interaction between proteins involved in extracellular matrix and endocytosis, regulation of chaperones and ribosome structure is unknown.
2.5.25 Ankyrin Repeat And SOCS Box Containing 3 (ASB3)
ASB3 is part of ASB gene family involved in Erk1/2 and PI3K/Akt signal transduction pathways by regulation of MAP kinase and Akt phosphorylation, both implicated in smooth muscle proliferation in asthma117.
It may regulate lymphocyte differentiation through TNF-a receptor (TNFR) 2 ubiquitination by recruitment of E3 ubiquitin ligase adaptors: elongins-B/C118. While TNFR2 initiates immune modulation and tissue regeneration, signaling through TNFR1 triggers pro-inflammatory pathways119. Loss of TNFR2 signaling can impair expansion and stability of Tregs and decrease their sensitivity to IL-2. Moreover, through reciprocal PI3K/Akt pathway activation and phosphorylation of STAT5, ASB3 impairs Th17 differentiation and may impair IL-12 signaling through JAK2/STAT4 to favor Th2 rather than Th1 differentiation120, resulting in predominantly eosinophilic, rather than neutrophilic inflammation.
Recent GWAS study has associated three SNPs in a region of chromosome 2 near ASB3 and SOCS with degree of bronchodilation following inhalations of albuterol in asthma patients121, with our study indicating ASB3 as an agent in the disease pathogenesis.
2.5.26 Solute carrier family 19 member 1 (SLC19A1)
SLC19A1, also referred to as reduced folate carrier protein, is a bidirectional membrane anion transporter enabling both folate and anti-folate medications, e.g. methotrexate (MTX) influx into the cell. Folate is required for synthesis of purines and thymine, homocysteine-methionine metabolism, both homocysteine-dependent and independent production of nitric oxide and reactive oxygen species (ROS) as well as DNA methylation, exerting both anti-inflammatory and pro-inflammatory properties, possibly depending on chronicity of an inflammatory disease122.
Folate deficiency was previously linked to asthma severity123 as well as risk of developing the disease in children of folate-deficient mothers124. It affects fibroblast expression of genes related to cytoskeleton remodeling, extracellular matrix and signaling through Wnt pathway (DKK1, WISP1 and WNT5A) 125 and may affect collagen metabolism in concomitant ascorbic acid deficiency. Folate deficiency increases the CD4/CD8 ratio and murine models indicate its role in maintaining CD4(+)Foxp3(+) regulatory T-cells, decreased in human asthma patients126.
Furthermore, as a recently discovered major transporter of immunoreactive cyclic dinucleotides (CDN) of autologous or microbial origin127, SLC19A1 may take part in dysregulation of the cGAS‐STING pathway which overactivation can drive inflammatory lung diseases, including asthma128.
A genetic risk factor of atopy, an SNP rs12483377-A is mapped to SLC19A1 and COL18A1, both functionally implied in the process19.
Up-regulation of SLC19A1 may be driven by transcription factors linked to asthma (CEBPB, USF1, SP1), Th2-differentiation (CEBPB)122 and asthma-specific mitochondrial biogenesis (NRF-1). Furthermore, it is up-regulated by vitamin D129, which deficiency was previously linked to asthma control. Differential co-expression in EA may indicate both activity of the above transcription factors, cell proliferation status or impaired reaction to folate deficiency, a condition under which SLC19A1 is considered cytotoxic, since it may aggravate folate deprivation by expulsion of folate monoglutamates130. These facts indicate that SLC19A1 may have pathogenetic role in asthma, being affected by both transcription factors involved in asthma and nutritional status linked to asthma risk and severity.
We hypothesize that ill-regulated overexpression of SLC19A1 by activity of transcription factors to asthma pathogenesis in a bystander effect may sensitize cells to pro-inflammatory effects of self- and microbial DNA or aggravate cell folate deprivation, activating cGAS-STING pathway or creating a vicious cycle of abnormal DNA methylation and exhibition of folate’s pro-inflammatory properties.
Co-expression of SLC19A1 in EA patients may have therapeutic implications, since MTX is consideration as steroid-sparing medication for severe asthma patients and its transport may affect treatment outcomes.
2.5.27 MAEA (macrophage erythroblast attacher, E3 ubiquitin ligase).
MAEA is an ubiquitin ligase and part of CTLH complex of significance in TNF-a-mediated apoptosis, as well as erythropoiesis and macrophage maturation. An EWAS found association between trans-CpG site in MAEA and IL1RL1a, an isoform of IL1RL1 associated with multiple immune reactions in the lung, including Th2-response131. MAEA methylation positively correlated to birth weight in an observational study132, suggesting possible mechanistic association between obesity, MAEA and IL1RL1a activity in asthma. As an apoptosis-related gene it is up-regulated upon exposure to cigarette smoke extract, possibly due to circulating TNF-a, placental growth factor or loss of VEGF signaling, as well as RSV exposure, along with MMP-9133.
2.5.28 DGLUCY (D-glutamate cyclase; C14orf159).
C14orf159 is a nuclear gene encoding mitochondrial protein recently identified as D-glutamate cyclase (DGLUCY) converting D-glutamate to 5-oxy-proline (pyroglutamic acid).
DGLUCY can be linked to asthma through (1) impact on E-cadherin expression (involved in to epithelial integrity in asthma), possibly through inhibition of ERK and P90RSK phosphorylation134, (2) its suppression by miRNA-199b (overexpressed during bacterial but not viral infections)135, (3) possibly related differential expression in neutrophilia136, (4) strong differential expression implied in seasonal remodeling of the immune system (reinforcing its role in immune system function and possibly regulation)137.
Expression of DGLUCY is influenced by signaling through oestrogen receptor alpha137, possibly adding to mechanisms of different asthma phenotypes between sexes. Similarly to abovementioned MRPL14, it is a downstream target of MYC, a transcription factor promoting mitochondrial biogenesis and oxidative metabolism in preparation for mitosis and obligatory for cell cycle entry and progression, with NRF-2 and MYC-interacting YY1 being the other transcription factor involved. Invertebrate studies of potential human application, given highly conservative nature of DGLUCY, identify MYC as regulated by TOR, FOXO and PI3K/Akt pathway in response to nutrient deprivation, linking nutrient availability with macromolecular synthesis enabled by mitochondrial biogenesis138.
2.5.29 RADX (RPA1 related single stranded DNA binding protein, X-linked; CXorf57)
RADX is one of the genes upregulated upon culture of pericytes under conditions differentiating them into mesenchymal stromal cells139. It is recognized, that migration of subepithelial microvascular pericytes contribute to airway remodeling; if involved in asthma, pericytes can form a source of mesenchymal cells for myofibroblast differentiation as in the murine model140 and RADX may indicate or mediate such transition.
2.5.30 Asthma ignorome:
We couldn’t find relevant associations with asthma, inflammation, airway remodeling or other DCGs for GOLGA2P3Y, RP11-321E2.2 and RP3-473B4.3. They will become part of asthma ignorome141 of currently unknown role until proven otherwise by future studies.
2.6 Regulatory networks of differentially co-expressed genes and inferred pathways.
Regulatory networks of DCGs are presented in Figures 5-6. Associated transcription factors were plotted against betweenness centrality of combined regulatory network to identify highly connected nodes with low literature representation and thus presenting research opportunities (Fig. 7). An enrichment analysis of the transcription factors revealed multiple signaling pathways listed in Tab. 11. Exceptional enrichment of SMAD2/3 nuclear signaling regulation corresponds to profibrotic effects of TGF-β/Smad2/3 pathway involved in fibroblast to myofibroblast transition85. Activator protein-1 pathway is necessary for transcription of Th2-profile cytokine IL-4 and indicated as therapeutic target in asthma142c. The E2F/Rb and Wnt/b-catenin pathways are both implied in airway smooth muscle hypertrophy143,144. This concordance with current literature validates our results and suggests other less studied pathways as important for future studies.